- to
monotherapies, and the FDA
recently approving therapeutic combination regimens that
demonstrated superior safety and
efficacy to
monotherapies. In...
-
against placebo, or that it is more
effective than an
existing drug. In
monotherapy (where only one drug is taken) it is
considered unethical by most to...
-
treatment of
schizophrenia as well as
bipolar depression, as
either monotherapy or
adjunctive therapy (with
lithium or valproate). It is
developed by...
-
Multiple studies suggest hydrochlorothiazide could be used as
initial monotherapy in
people with
primary hypertension; however, the
decision should be...
- and Drug
Administration (FDA) to
treat bipolar depression,
either as
monotherapy or
adjunctively with
lithium or valproate.
Generic versions were approved...
- (i.e.,
doses given to oneself) in humans, but it is not an
effective monotherapy for
amphetamine addiction. A
systematic review and meta-analysis from...
-
Weston J,
Tudur Smith C (August 2018). "Sodium
valproate versus phenytoin monotherapy for epilepsy: an
individual parti****nt data review". The
Cochrane Database...
-
Lumateperone (Caplyta) –
approved as a
monotherapy for
bipolar depression Lurasidone (Latuda) –
approved as a
monotherapy for
bipolar depression Quetiapine...
- Group) (February 2020). "First-line
combination therapy versus first-line
monotherapy for
primary hypertension". The
Cochrane Database of
Systematic Reviews...
- of
chloroquine or
hydroxychloroquine to COVID-19 patients,
either as
monotherapies or in
conjunction with azithromycin, has been ****ociated with deleterious...
